22 February 2021>: Articles
The Clinical Course of COVID-19 Pneumonia in a 19-Year-Old Man on Intravenous Immunoglobulin Replacement Therapy for X-Linked Agammaglobulinemia
Unusual or unexpected effect of treatment, Rare coexistence of disease or pathology
Ali Almontasheri A* , Faisal Al-Husayni E , Anas K. Alsuraihi B , Hanan Binyahib F , Amr S. Albanna EDOI: 10.12659/AJCR.929447
Am J Case Rep 2021; 22:e929447
Table 2. Patient’s initial blood work at the time of COVID-19 diagnosis.
Laboratory test | Result | Reference range |
---|---|---|
White blood count | 9.9×10/L | 4.0–11.0×10/L |
Hemoglobin | 14.5 g/dL | 11.5–16.5 g/dL |
Platelet | 325×10/L | 150–450×10/L |
Neutrophil count | 6.8×10/L | 2–7.5×10/L |
Lymphocyte count | 2.15×10/L | 1.5–4×10/L |
C-reactive protein | 47.6 mg/L | 0–5 mg/L |
Erythrocyte sedimentation rate | 43 mm/h | 0–20 mm/h |
Ferritin | 58 ug/L | 11–313 ug/L |
Procalcitonin | 0.05 ug/L | ≥0.25 ug/L |
Lactate dehydrogenase | 305 U/L | 100–217 U/L |
D-dimer | 0.78 mg/L | 0–0.5 mg/L |